InvestorsObserver
×
News Home

Analyst Rating: Will Cardlytics Inc (CDLX) Stock Outperform the Market?

Monday, November 27, 2023 02:13 PM | InvestorsObserver Analysts

Mentioned in this article

Analyst Rating: Will Cardlytics Inc (CDLX) Stock Outperform the Market?

InvestorsObserver is giving Cardlytics Inc (CDLX) an Analyst Rating Rank of 20, meaning CDLX is ranked higher by analysts than 20% of stocks. The average price target for CDLX is $10 and analyst’s rate the stock as a Buy.

Overall Score - 3.5
Wall Street analysts are rating CDLX a Buy today. Find out what this means to you and get the rest of the rankings on CDLX!

Why are Analyst Ratings Important?

Analysts know the inner workings of the companies they follow better than anyone but the companies’ management. You can learn a lot about a company from studying the financial statements, but analysts ask questions on conference calls and understand the intricacies of each of the businesses they cover. Analysts understand how bad weather in one part of the world can disrupt supply chains, or disrupt shopping patterns. This lets traders make decisions before a quarterly report that could be worse than expected. InvestorsObserver aggregates the ratings of all the analysts covering a given stock, takes the average of those ratings and then percentile ranks the averages. That provides a level of granularity that is significantly better than just the three levels provided by traditional buy/hold/sell ratings.

What's Happening With Cardlytics Inc Stock Today?

Cardlytics Inc (CDLX) stock is trading at $7.56 as of 2:12 PM on Monday, Nov 27, a drop of -$0.27, or -3.45% from the previous closing price of $7.83. The stock has traded between $7.47 and $7.81 so far today. Volume today is less active than usual. So far 147,836 shares have traded compared to average volume of 960,866 shares. Click Here to get the full Stock Report for Cardlytics Inc stock.

You May Also Like

Get the InvestorsObserver App

InvestorsObserver App
iOS App Android App